NHS Framework Agreement - North of England - Tranche B

NHS EnglandcontractContracts Finder ↗Ref tender_218592/840270SME suitablecomplete

Estimated value

£514.0m

Awarded value

£205.5m

Awarded 13 Feb 2020

Suppliers

1

Lots

1

1 awarded

Published

25 Mar 2020

Deadline 07 Nov 2019

Awarded suppliers· 1 supplier

Awarded 13 Feb 2020 · Contract period 01 Mar 2020 — 28 Feb 2022

Award value

£205.5m

1

AP

ACRE PHARMA LIMITED,AMGEN LIMITED,ASPEN PHARMA LTD,ASTELLAS PHARMA LTD.,SANOFI-AVENTIS UK HOLDINGS LIMITED,BAYER PUBLIC LIMITED COMPANY,BIOGEN LTD,BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED,CELLTRION HEALTHCARE UNITED KINGDOM LIMITED,DAIICHI SANKYO UK LIMITED,DAIICHI SANKYO UK LIMITED,DR. REDDY'S LABORATORIES (EU) LIMITED,ELI LILLY AND COMPANY LIMITED,FERRING PHARMACEUTICALS LIMITED,GEDEON RICHTER (UK) LIMITED,MYLAN LIMITED,GILEAD SCIENCES LTD,IPSEN LIMITED,JANSSEN-CILAG LIMITED,JANSSEN-CILAG LIMITED,MERCK SERONO LIMITED,MERCK SHARP & DOHME LIMITED,NAPP LABORATORIES LIMITED,NOVARTIS PHARMACEUTICALS UK LIMITED,NOVO NORDISK LIMITED,PFIZER LIMITED,PHARMASURE LIMITED,PROFILE PHARMA LIMITED,ROCHE PRODUCTS LIMITED,ROVI BIOTECH LIMITED,SANDOZ LIMITED,TAKEDA UK LIMITED,TECHDOW PHARMA ENGLAND LIMITED,TEVA UK LIMITED,THERAMEX HQ UK LIMITED,TYPHARM LIMITED,UCB PHARMA LIMITED